North America tissue banking market is expected to grow by 8.5% annually in the forecast period and reach $17.82 billion by 2030 owing to the increasing demand for regenerative medicines and advancements in tissue preservation and in-house sample testing, an increasing number of biobanks across the globe, and the advancements in the medical drug discovery and biopharmaceuticals industry.
Highlighted with 24 tables and 56 figures, this 111-page report “North America Tissue Banking Market 2020-2030 by Offering (Equipment, Accessories & Consumables, Services), Application (Therapeutics, Medical Research, Cosmetics), Tissue Type (Cardiovascular, Corneal, Lung, Kidney, Bone, Skin), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America tissue banking market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America tissue banking market in every aspect of the classification from perspectives of Offering, Application, Tissue Type, End User, and Country.
Based on Offering, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
o Cryopreservation Equipment
o Thawing Equipment
o Quality Control Equipment
o Labeling and Coding Equipment
o Alarming and Monitoring Systems
o Other Equipment
• Accessories and Consumables
o Tissue Retrieval
o Storage and Preservation
o Other Services
Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Medical Research
• Other Applications
Based on Tissue Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Cardiovascular Tissue
• Corneal Tissue
• Lungs Tissue
• Kidney Tissue
• Bone Tissue
• Skin Tissue
• Brain & Spinal Cord
• Others Tissue Types
Based on End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Hospitals and Clinics
• Research and Academic Institutes
• Other End Users
Geographically, the following national/local markets are fully investigated:
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Offering, Application, and Tissue Type over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
AMS Biotechnology Ltd.
Avantor Inc. (VWR International)
Beckman Coulter, Inc.
Bio-Rad Laboratories Inc.
Brooks Lifesciences (Brooks Automation Inc.)
Custom Biogenic Systems, Inc.
Organ Recovery Systems, Inc.
PHC Holdings Corporation
Taylor-Wharton International LLC
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)